Innovacell Inc. (504A) Stock Price & Analysis
504A Stock Chart & Stats
- Day’s Range
- $484.00 - $505.00
- 52-Week Range
- $377.00 - $1,248.00
- Previous Close
- $496.00
- Volume
- N/A
- Average Volume (3M)
- 77.50K
- Market Cap
- JPY 22.49B
- Enterprise Value
- JPY 9.78B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 0.63
- Next Earnings
- Nov 11, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Innovacell Inc. News
Innovacell Wins FDA Green Light to Globalize Phase III Trial for Fecal Incontinence Cell Therapy
Innovacell Inc. ( ($JP:504A) ) has issued an announcement. Innovacell Inc. has received clearance from the U.S. Food and Drug Administration for its Investigational New Drug application, allowing U.S. sites
Innovacell Launches Restricted Stock Plan With New Share Issuance for Directors
Innovacell Inc. ( ($JP:504A) ) just unveiled an announcement. Innovacell Inc. has approved the issuance of 53,400 new ordinary shares as restricted stock to three internal directors, excluding outside directors,
504A FAQ
What was Innovacell Inc.’s price range in the past 12 months?
What is Innovacell Inc.’s market cap?
When is Innovacell Inc.’s upcoming earnings report date?
How were Innovacell Inc.’s earnings last quarter?
Is Innovacell Inc. overvalued?
Does Innovacell Inc. pay dividends?
What is Innovacell Inc.’s EPS estimate?
How many shares outstanding does Innovacell Inc. have?
What happened to Innovacell Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Innovacell Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Innovacell Inc.
Innovacell Inc. is a biotech company that develops, manufactures, and sells cell therapy and regenerative medicine products aimed at treating fecal and urinary incontinence. The company's pipeline includes treatments for urgent fecal incontinence, leaky fecal incontinence, and stress urinary incontinence using the patient's own cells.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Colin Lee Novick
- Employees
- 48
- Website
- www.innovacell.com
- Address
- MEGURO VILLA GARDEN 5F, Tokyo, TY, 141-0021, JP
Innovacell Inc. (504A) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 5 | 8 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 4 | 0 | 6 |
